Igene Biotechnology
IGNE · OTC
$0.00+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
Key indicators
IGNE profitability and balance sheet ratios
EPS -$0.0004 in Sep 2010, down 500.0% on a year earlier.
| Period | EPS |
|---|---|
| Dec 2008 | -$0.0073 |
| Mar 2009 | $0.0005 |
| Jun 2009 | -$0.0004 |
| Sep 2009 | $0.0001 |
| Dec 2009 | -$0.0002 |
| Mar 2010 | -$0.0004 |
| Jun 2010 | -$0.0005 |
| Sep 2010 | -$0.0004 |
Income statement
No financial statements are reported for Igene Biotechnology.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Mar 2010 | Jun 2010 | Sep 2010 |
|---|---|---|---|
| Total assets | $4.6M | $4.0M | $3.4M |
| Total liabilities | $7.6M | $7.8M | $7.9M |
| Shareholder equity | −$3.0M | −$3.8M | −$4.4M |
| Cash and short-term investments | $1.3M | $1.0M | $0.3M |
| Total debt | $1.9M | $2.0M | $2.0M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.